Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Radiol Case Rep ; 15(3): 246-249, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31956381

ABSTRACT

Four-dimensional computed tomography has been used to evaluate moving structures and is a useful method to diagnose cardiovascular diseases. We report a case of cerebral infarction due to the thrombus in the ascending aorta, and utilized 4-dimensional computed tomography angiography for visualizing the movement of the thrombus, which prompted early surgical intervention to prevent further thromboembolism. Although transesophageal echocardiography is an established method to evaluate the ascending aorta, it has some contraindications and complications. Four-dimensional computed tomography angiography is an excellent alternative without blind spots to evaluate the ascending aorta more quickly than transesophageal echocardiography.

2.
J Renin Angiotensin Aldosterone Syst ; 20(1): 1470320319834409, 2019.
Article in English | MEDLINE | ID: mdl-30843458

ABSTRACT

INTRODUCTION:: Angiotensin-converting enzyme (ACE) inhibitors are one of the most commonly used medications for hypertension. Rarely, ACE inhibitors have the potential to cause a syndrome of inappropriate secretion of antidiuretic hormone (SIADH). CASE PRESENTATION:: A 70-year-old woman with > 10 years ACE inhibitor therapy with normonatremia suddenly developed severe SIADH when she took a liquid diet in the uneventful perioperative period, with hemodynamic stability and no surgical complications. She promptly recovered from SIADH subsequent to discontinuing the ACE inhibitor therapy and changing her diet. Therefore, it was assumed that excess antidiuretic hormone secretion due to an ACE inhibitor and free water load from the liquid diet contributed to hyponatremia in our patient. CONCLUSION:: Patients treated with an ACE inhibitor can latently experience inappropriate secretion of antidiuretic hormone, and rapidly develop severe hyponatremia together with additional factors affecting water or salt homeostasis regardless of the length of the administration duration. Clinicians should monitor serum sodium levels in such patients not only just after the initiation of ACE inhibitors but also upon the appearance of those factors.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/adverse effects , Inappropriate ADH Syndrome/chemically induced , Inappropriate ADH Syndrome/surgery , Perioperative Period , Aged , Disease Progression , Female , Humans
3.
Parkinsonism Relat Disord ; 19(1): 104-8, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22981261

ABSTRACT

OBJECTIVE: This multicenter cross-sectional study aimed to investigate the clinical features and varieties of non-motor fluctuation in Parkinson's disease (PD). METHODS: To identify motor and non-motor fluctuation, we employed the wearing-off questionnaire of 19 symptoms (WOQ-19) in 464 PD patients. We compared the frequency of levodopa-related fluctuation as identified by the WOQ-19 with recognition by neurologists. We compared patients with both motor and non-motor fluctuations with those who only had motor fluctuations. Non-motor fluctuations were separated into psychiatric, autonomic, and sensory categories for further analysis. RESULTS: The patients' average age was 70.8 ± 8.4 years (mean ± SD) and disease duration was 6.6 ± 5.0 years. The frequency of motor fluctuations was 69% and for non-motor fluctuation 40%. Fifty-three percent of patients with motor fluctuations also had non-motor fluctuations, whereas 93% of patients with non-motor fluctuations also had motor fluctuations. The WOQ-19 showed a sensitivity of 82% but a specificity of only 40%. The patients with both non-motor and motor fluctuations exhibited more severe motor symptoms, more non-motor symptoms and higher levodopa daily doses (p < 0.05). Patients had significantly higher fluctuation rates if they had psychiatric (49%) and sensory (45%) symptoms than patients with autonomic symptoms (32%, p < 0.01). Forty-eight percent of patients with non-motor fluctuations exhibited more than one type of non-motor fluctuation. CONCLUSION: Forty percent of PD patients presented with non-motor fluctuations, and almost half of these exhibited more than one type. Appropriate recognition of levodopa-related fluctuations, both motor and non-motor, can lead to treatment modifications in PD patients.


Subject(s)
Levodopa/therapeutic use , Movement Disorders/drug therapy , Parkinson Disease/drug therapy , Parkinson Disease/psychology , Aged , Aged, 80 and over , Asian People , Cross-Sectional Studies/methods , Female , Humans , Male , Middle Aged , Motor Activity/physiology , Surveys and Questionnaires/standards
4.
J Neurol ; 259(8): 1606-12, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22231870

ABSTRACT

REM sleep behavior disorder (RBD) is known to be observed more frequently in patients with an α-synucleinopathy such as Parkinson's disease (PD) than in the general population. The precise prevalence of RBD in Japanese PD patients is not known. Therefore, we investigated the prevalence and the clinical characteristics of patients with RBD in a large population of Japanese patients with PD. We investigated various clinical features and employed the Japanese version of the RBD screening questionnaire on 469 non-demented Japanese PD patients in this multicenter study. Probable or possible RBD was detected in 146 patients (31.1%) and was significantly associated with longer PD duration, higher Hoehn and Yahr stage, higher Unified Parkinson's Disease Rating Scale part III subscale (7 items), more motor fluctuations, and a higher levodopa-equivalent daily dose (p < 0.01). As to the major autonomic dysfunctions, severe constipation was significantly more frequent in PD patients with RBD than in those without it (p < 0.01). The RBD symptoms of 53 patients (39.0%) preceded the onset of PD motor symptoms. The median interval from the onset of RBD symptoms to PD motor symptoms was 17.5 years, and 3 patients had intervals of over 50 years. This large-scale multicenter study revealed that RBD is a frequent non-motor symptom in Japanese patients with PD, which may precede the onset of motor symptoms. Moreover, RBD that increases with the duration and severity of PD may be associated with autonomic dysfunction.


Subject(s)
Asian People/ethnology , Mass Screening/methods , Parkinson Disease/diagnosis , Parkinson Disease/ethnology , REM Sleep Behavior Disorder/diagnosis , REM Sleep Behavior Disorder/ethnology , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Mass Screening/standards , Middle Aged , Surveys and Questionnaires/standards
5.
Mov Disord ; 26(14): 2567-71, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21953897

ABSTRACT

OBJECTIVE: The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients. BACKGROUND: Although camptocormia has been recognized as a prominent phenomenon in PD, the previous epidemiological reports were limited, especially in terms of sample size. METHODS: We evaluated 531 PD patients (disease duration: 7.0 ± 5.5 years, mean ± standard deviation). We examined their clinical features and the prevalence of camptocormia. RESULTS: Camptocormia was detected in 22 patients (4.1%) and found in patients who were older and had more severe motor symptoms and a higher levodopa (L-dopa) dose (P < 0.05), compared to the patients without camptocormia. Patients with camptocormia showed significantly higher frequencies of autonomic symptoms, such as constipation and urinary incontinence (P < 0.05). CONCLUSIONS: Camptocormia is uncommon in PD and is associated with disease severity, higher L-dopa dose and higher frequencies of autonomic symptoms.


Subject(s)
Asian People/statistics & numerical data , Muscular Atrophy, Spinal/epidemiology , Parkinson Disease/epidemiology , Spinal Curvatures/epidemiology , Aged , Aged, 80 and over , Antiparkinson Agents/administration & dosage , Comorbidity , Cross-Sectional Studies , Female , Humans , Japan/epidemiology , Levodopa/administration & dosage , Male , Parkinson Disease/drug therapy , Prevalence , Severity of Illness Index
6.
Rinsho Shinkeigaku ; 47(2-3): 73-8, 2007.
Article in Japanese | MEDLINE | ID: mdl-17511272

ABSTRACT

We report a 66-year-old man with spreading lesion over the bilateral splenia of the corpus callosum shown on MRI. On admission, unknown fever and myoclonus-like involuntary movement in the left forefinger and middle finger were observed. There were no remarkably abnormal data in the serum, the cerebrospinal fluid and electroencephalogram. However, T2-weighted MRI revealed the high signal spreading over the bilateral splenia of the corpus callosum, while enhanced effects were not observed by Gd contrast on T1-weighted MRI. Diffusion and FLAIR MRI also showed the high signals limited to the same part of the splenia bilaterally as on T2-weighted MRI, discriminating it from other lacunar lesions and old cerebral infarctions. Neurological features, which were considered to be directly associated with the fresh lesion, were impairment of verbal and visual memories. Near the time the therapies including high-dose steroid were given, the consciousness of the patient worsened rapidly on a day-to-day basis and disseminated intravascular coagulation syndrome (DIC) also occurred. By administering low-molecule heparin, consciousness disturbance and involuntary movements recovered completely. Following the improved symptoms, FLAIR MRI showed a reduced level of the signal seven months after the onset. A demyelinating disease over the bilateral splenia of the corpus callosum should be considered as the final diagnosis. Follow-up of the changes in this case is expected to provide a more accurate diagnosis.


Subject(s)
Consciousness Disorders/etiology , Corpus Callosum/pathology , Encephalomyelitis, Acute Disseminated/etiology , Encephalomyelitis, Acute Disseminated/pathology , Fever/complications , Magnetic Resonance Imaging , Aged , Atrophy , Communicable Diseases/complications , Consciousness Disorders/therapy , Disseminated Intravascular Coagulation/etiology , Disseminated Intravascular Coagulation/therapy , Encephalomyelitis, Acute Disseminated/therapy , Humans , Male , Myoclonus/etiology , Myoclonus/therapy , Prognosis
7.
Rinsho Shinkeigaku ; 44(6): 372-4, 2004 Jun.
Article in Japanese | MEDLINE | ID: mdl-15293762

ABSTRACT

A 40-year-old man was admitted to our hospital because of consciousness disturbance, dysarthria and numbness in his right hand. Computed tomography of the head showed a cerebral hemorrhage of the left putamen. The patient was judged to have an indication of operation, and frontal craniotomy to evacuate hematoma was performed. During the operation, massive whitish pus flowed out at the time of surgery. Therefore, hemorrhage into a brain abscess was diagnosed. We reported this unique and interesting case whose brain abscess could not be differentiated from an ordinary hypertensive putaminal hemorrhage based on clinical findings and CT image. This diagnosis was not made until the patient was operated on through a craniotomy.


Subject(s)
Brain Abscess/diagnosis , Craniotomy , Putaminal Hemorrhage/surgery , Adult , Brain Abscess/etiology , Humans , Male , Putaminal Hemorrhage/complications , Putaminal Hemorrhage/diagnostic imaging , Tomography, X-Ray Computed
8.
Keio J Med ; 53(1): 7-11, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15096722

ABSTRACT

Obesity is widely recognized as a risk factor for coronary artery disease, but opinion is divided regarding whether it is an independent risk factor for cerebrovascular disease; even now there is no common view. In this study, the review sought to focus on a prospective study, but since obesity and non-obesity basically cannot be randomly assigned, randomized controlled trials (RCT) are nonexistent. Accordingly, a cohort study (a method of clinical study in which the obesity group is actively followed up for comparison with the non-obesity group in regard to cerebrovascular disease) was mainly conducted. For reference, retrospective case-control studies are also shown. As a result, most epidemiological surveys on the relation between simple obesity and cerebrovascular disease denied any relation. That is, obesity alone, determined only on the basis of height and weight as shown by BMI (body mass index), etc., cannot be an independent risk factor for cerebrovascular disease; obesity can become a risk factor only when accompanied by hypertension, hyperlipidemia, impaired glucose tolerance, etc. Recently, however, most papers conclude that abdominal obesity is a risk factor for cerebral infarction, provided that there are no data confirming that obesity is a risk factor for hemorrhagic cerebrovascular disease (cerebral hemorrhage and subarachnoid hemorrhage).


Subject(s)
Cerebrovascular Disorders/complications , Obesity/complications , Risk Factors , Body Mass Index , Case-Control Studies , Cerebral Hemorrhage/epidemiology , Cerebrovascular Disorders/diagnosis , Cohort Studies , Humans , Obesity/diagnosis , Retrospective Studies , Subarachnoid Hemorrhage/epidemiology
9.
Rinsho Shinkeigaku ; 43(8): 470-6, 2003 Aug.
Article in Japanese | MEDLINE | ID: mdl-14658398

ABSTRACT

A previously healthy 30-year-old woman was admitted to our hospital because of impaired consciousness after convulsion. A temporary diagnosis of herpes simplex encephalitis was made, and intravenous acyclovir (ACV) therapy (250 mg four times daily in normal saline over 2 hours) was started. Three days later, she became confused, and was having hallucinations, dysarthria and generalized painful seizures occurred without focal neurologic deficit. Whether the neuropsychiatric symptoms were related to herpes simplex encephalitis or acyclovir neurotoxity was initially unclear. The brain MRI and lumbar puncture findings were initially normal, but abnormal FLAIR lesions appeared later. ACV-associated encephalopathy was considered. ACV was discontinued, and she recovered from the neurological disorder within 24 hours. Although blood levels of acyclovir were not determined, it is unlikely that they were in a toxic range, in view of her normal renal function.


Subject(s)
Acyclovir/adverse effects , Antiviral Agents/adverse effects , Brain Diseases/chemically induced , Brain Diseases/psychology , Encephalitis, Viral/drug therapy , Acute Disease , Adult , Brain Diseases/diagnosis , Dysarthria/chemically induced , Epilepsy, Generalized/chemically induced , Female , Hallucinations/chemically induced , Humans , Kidney Diseases , Magnetic Resonance Imaging
10.
Acta Haematol ; 108(1): 47-52, 2002.
Article in English | MEDLINE | ID: mdl-12145468

ABSTRACT

We describe a 69-year-old Japanese male with acute leukemia with a CD7+ and CD56+ immunophenotype presenting with multiple lymphadenopathy. He was treated with idarubicin and cytosine arabinoside. Although the leukemia showed partial response, the patient did not achieve complete remission. He died of sepsis due to severe neutropenia after the third course of chemotherapy. His autopsy revealed blast infiltration in the lymph nodes, liver, spleen and vertebral bone marrow. Recently, CD7+ and CD56+ myeloid/natural killer precursor acute leukemia has been associated with a poor prognosis. Our case illustrates that myeloid/natural killer cell precursor acute leukemia shows some response to intensive chemotherapy for acute myeloid leukemia, but such therapy is insufficient to effect a cure. To overcome the resistance of this disease to chemotherapy, further studies should explore other treatment strategies.


Subject(s)
Antigens, CD7/analysis , Antigens, Neoplasm/analysis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , CD56 Antigen/analysis , Cytarabine/analogs & derivatives , Killer Cells, Natural/pathology , Leukemia, Myeloid/drug therapy , Myeloid Cells/pathology , Neoplastic Stem Cells/pathology , Acute Disease , Aged , Antigens, CD/analysis , Antigens, Differentiation, Myelomonocytic/analysis , Cytarabine/administration & dosage , Daunorubicin/administration & dosage , Diagnosis, Differential , Etoposide/administration & dosage , Fatal Outcome , Humans , Idarubicin/administration & dosage , Killer Cells, Natural/chemistry , Leukemia, Myeloid/diagnosis , Leukemia, Myeloid/pathology , Leukemic Infiltration , Lymphoma, Non-Hodgkin/diagnosis , Male , Mercaptopurine/administration & dosage , Mitoxantrone/administration & dosage , Myeloid Cells/chemistry , Neoplastic Stem Cells/chemistry , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Sarcoma, Myeloid/diagnosis , Sialic Acid Binding Ig-like Lectin 3
SELECTION OF CITATIONS
SEARCH DETAIL
...